Evidence map›Paper›PMID 36855470›Full record

ArticleACS organic & inorganic Au2022

Effects of Ancillary Ligands on Deep Red to Near-Infrared Cyclometalated Iridium Complexes.

Po Ni Lai, Sungwon Yoon, Yumeng Wu, Thomas S Teets

Abstract read
In one paragraph

Article in ACS organic & inorganic Au, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Po Ni LaiDepartment of Chemistry, University of Houston, Lamar Fleming Jr. Building, 3585 Cullen Boulevard, Room 112, Houston, Texas 77204-5003, United States.
Sungwon YoonDepartment of Chemistry, University of Houston, Lamar Fleming Jr. Building, 3585 Cullen Boulevard, Room 112, Houston, Texas 77204-5003, United States.
Yumeng WuDepartment of Chemistry, University of Houston, Lamar Fleming Jr. Building, 3585 Cullen Boulevard, Room 112, Houston, Texas 77204-5003, United States.ORCID https://orcid.org/0000-0002-0205-0728
Thomas S TeetsDepartment of Chemistry, University of Houston, Lamar Fleming Jr. Building, 3585 Cullen Boulevard, Room 112, Houston, Texas 77204-5003, United States.ORCID https://orcid.org/0000-0002-7471-8467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of organometallic compounds with efficient phosphorescence in the deep red to near-infrared portions of the spectrum is a long-standing fundamental challenge. Here we describe a series of heteroleptic bis-cyclometalated iridium complexes with phosphorescence in these low-energy regions of the spectrum. The cyclometalating ligands in this study feature a metalated benzothiophene aryl group substituted with a quinoline, isoquinoline, or phenanthridine heterocycle. Increasing the conjugation on the heterocycle stabilizes the ligand-centered LUMO, decreases the HOMO-LUMO gap, and enables phosphorescence to occur at long wavelengths. These cyclometalating ligands are paired with a variety of electron-rich ancillary ligands, such as dithiocarbamate (dipdtc), β-ketoiminate (acNac), β-diketiminate (NacNac), amidinate (dipba), and hexahydropyrimidopyrimidine (hpp), some of which have significant influences on the phosphorescence wavelength and excited-state dynamics. The syntheses of seven compounds in this series are described, three of which are structurally validated by single-crystal X-ray diffraction. Cyclic voltammetry reveals the effects of ligand modification on the frontier orbital energies. The photophysical properties of all compounds are thoroughly characterized by UV-vis absorption spectroscopy and steady-state photoluminescence at room-temperature and 77 K. Photoluminescence quantum yields and lifetimes of all compounds are reported.

Identifiers

PMID36855470
PMCPMC9954257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.